Genetic Engineering, Humankind Creeps Toward A 'Planet Of The Apes'
By Laurent Alexandre,
World Crunch
| 04. 07. 2015
PARIS — Half-animal, half-human? The astounding developments in nanotechnology, biotechnology, information technology and cognitive science (NBIC) are posing problems that we thought only existed in science fiction.
Recent studies have brought us closer to Planet of the Apes, written by French novelist Pierre Boulle in 1963. In three experiments, the last one of which was published in Current Biology last month, scientists have improved the intellectual capacities of mice by modifying their DNA sequences with segments of human chromosomes or by injecting them with human brain glial cells.
These modified animals have bigger brains and can perform difficult tasks more quickly. The DNA sequences that were successfully modified are involved in language and brain size in humans. This comes after a study on successful genetic modifications on two small monkeys was published in Nature in March of last year. Meaning that the success of cognitive improvement of mice will soon be verified in monkeys.
These manipulations were achieved with DNA-modifying enzymes. For about $12, a biology student these days can create these enzymes and conduct genetic engineering, making it...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...